Abstract:The thrombopoietin analogue romiplostim was recently approved as a therapy for chronic immune thrombocytopenic purpura. It has showed good efficacy in stimulating a transient or sustained increase in platelet count in a majority of patients. Romiplostim's effect on bone marrow morphology has not been fully described, and we report on two patients on romiplostim therapy who underwent bone marrow biopsies. In both marrows, increased numbers of megakaryocytes with hyperplastic morphology, similar to that seen in … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.